Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015)

SELLAS Life Sciences (SLS) reported Amortization - Intangibles of $442000.0 for Q2 2015, up 351.02% year-over-year from $98000.0 in Q2 2014, and up 202.74% on a QoQ basis from $146000.0 in Q1 2015.

SELLAS Life Sciences (SLS) has 3 years of Amortization - Intangibles data on file, last reported at $442000.0 in Q2 2015.

  • Quarterly Amortization - Intangibles rose 351.02% year-over-year to $442000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $756000.0 (up 225.86% YoY) and the FY2017 annual result came in at $1.9 million, changed N/A from the prior year.
  • Amortization - Intangibles climbed to $442000.0 in Q2 2015 per SLS's latest filing, from $146000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $442000.0 in Q2 2015 and bottomed at $43000.0 in Q3 2013.
  • The 3-year median for Amortization - Intangibles is $94500.0 (2014), against an average of $148333.3.
  • Peak annual rise in Amortization - Intangibles reached 351.02% in 2015, while the deepest fall reached 60.44% in 2015.
  • Tracing SLS's Amortization - Intangibles over 3 years: stood at $43000.0 in 2013, then jumped by 62.79% to $70000.0 in 2014, then soared by 531.43% to $442000.0 in 2015.
  • Per Business Quant, the three latest SLS Amortization - Intangibles figures stand at $442000.0 (Q2 2015), $146000.0 (Q1 2015), and $70000.0 (Q3 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2015 442,000.00
Mar 31, 2015 146,000.00
Sep 30, 2014 70,000.00
Jun 30, 2014 98,000.00
Mar 31, 2014 91,000.00
Sep 30, 2013 43,000.00